Nasal floor expansion: MARPE nasal floor changes and collateral anatomical effects
Back to home
SKELETAL EXPANSION
Beyond the palate: what your CBCT reveals

MARPE and the Nasal Floor:
Collateral Anatomical Effects
Understanding three-dimensional skeletal remodeling during expansion

Miniscrew-assisted expansion produces significant nasal floor widening and paranasal remodeling. Learn the evidence-based anatomical patterns, clinical implications, and imaging protocols that separate predictable outcomes from complications.

MARPEnasal anatomyskeletal expansionthree-dimensional CBCT
TL;DR MARPE (miniscrew-assisted rapid palatal expansion) produces significant collateral anatomical effects beyond the palate, including nasal floor widening, increased nasal cavity dimensions, and remodeling of paranasal structures. A prospective randomized trial demonstrated greater nasal width increases in the molar region and greater palatine foramen changes in MARPE versus conventional RPE, with potential implications for nasal airway function and long-term stability.

The nasal floor and adjacent skeletal structures undergo predictable but often underappreciated remodeling during miniscrew-assisted rapid palatal expansion (MARPE). While clinicians focus on midpalatal suture separation and transverse maxillary width gains, the collateral anatomical effects — including nasal floor remodeling, paranasal sinus wall displacement, and vomer repositioning — deserve equal clinical attention. Dr. Mark Radzhabov and other leaders in skeletal expansion have increasingly documented these secondary changes using three-dimensional CBCT analysis, revealing that MARPE produces more favorable nasal floor widening than tooth-borne RPE in comparable cases. Understanding these collateral effects is essential for predicting airway changes, explaining treatment outcomes to patients, and optimizing case selection in older adolescents and adults.

OVERVIEW
*The nasal floor is not a silent bystander*

What is MARPE nasal floor remodeling?
Collateral anatomical
effects during skeletal expansion

When miniscrew-assisted rapid palatal expansion (MARPE) is activated, the resulting orthopedic forces do not confine themselves to the midpalatal suture. Instead, the entire transverse dimension of the maxilla — including the nasal floor, lateral nasal walls, vomer, and paranasal structures — undergoes coordinated skeletal remodeling. This phenomenon reflects the biomechanics of MARPE, where force application at the palatal level transmits stress through interconnected bony and sutural pathways, ultimately affecting structures well above the hard palate.

The nasal floor, bounded medially by the vomer and laterally by the pterygoid plates and pyriform aperture, is particularly susceptible to remodeling because it sits directly above the expanding palate. As the palate widens, the vomer — which articulates with the midpalatal suture — separates and tilts, widening the nasal cavity floor. Paranasal structures, including the medial walls of the maxillary sinuses and the floor of the nasal cavity proper, respond to these orthopedic forces by remodeling rather than resisting, creating a three-dimensional transformation that extends far beyond the dental arches.

A prospective randomized clinical trial comparing conventional RPE and MARPE in adolescents and young adults demonstrated that MARPE produced significantly greater increases in nasal width in the molar region and greater palatine foramen changes compared to tooth-borne expansion, despite identical 35-turn activation protocols. This finding underscores that skeletal anchorage produces qualitatively different — and often more orthopedic — expansion patterns than dental anchorage. The clinical implication is profound: MARPE not only achieves greater transverse skeletal gains. It redistributes those gains across a broader anatomical canvas, including structures critical to nasal airway patency and facial balance.

Understanding nasal floor remodeling is essential because these collateral anatomical changes influence patient-reported airway improvements, long-term stability, and the severity of dentoalveolar side effects (such as buccal flaring). Clinicians who can predict and monitor nasal floor widening gain a significant advantage in case selection, patient counseling, and treatment outcome verification.

Chun et al. (2022) BMC Oral Health prospective randomized trial comparing RPE and MARPE skeletal and alveolar changes in 40 adolescents and young adults using low-dose CBCT.
ANATOMY & IMAGING
*See what happens: the CBCT evidence*

Nasal cavity widening and paranasal
skeletal remodeling
patterns visible on three-dimensional imaging

The nasal cavity is not a simple tube. It is a complex three-dimensional space bounded by multiple bony walls, each of which responds differently to transverse expansion forces. The floor of the nasal cavity is formed by the hard palate and the horizontal plates of the palatine bones, while the medial wall is the vomer, a midline septal structure that articulates directly with the midpalatal suture. During MARPE, as the midpalatal suture widens, the vomer separates and tilts laterally, increasing the transverse dimension of the nasal floor. Simultaneously, the lateral nasal walls (formed by the medial surfaces of the maxillary sinuses and the pyriform aperture) widen as the maxilla expands transversely.

CBCT imaging reveals that paranasal sinus walls, particularly the medial walls of the maxillary sinuses, undergo inward remodeling — that is, the sinus volume may initially decrease or remain stable despite overall maxillary widening, because the sinus walls move medially as the lateral maxillary walls expand outward. This “paradoxical” pattern is a normal consequence of skeletal expansion and does not indicate pathology. The greater palatine foramen, which transmits the greater palatine neurovascular bundle, also widens during MARPE, reflecting the separation of the palatal shelves. Measurement of palatine foramen width before, immediately after, and during the consolidation phase provides an objective marker of skeletal expansion depth and can serve as a quality control metric during treatment.

A key imaging protocol involves measuring nasal width at three standardized levels: at the level of the molar teeth (M-NW), at the premolar region (PM-NW), and at the nasal aperture. This multi-level approach captures the three-dimensional nature of nasal floor widening and allows clinicians to verify that expansion is occurring orthopedically (broad nasal widening) rather than through dentoalveolar compensation alone (narrow nasal widening with excessive buccal flaring of anchor teeth). Low-dose CBCT protocols, now standard in many orthodontic offices, provide sufficient resolution to identify sutural landmarks, vomer position, and paranasal wall geometry without exceeding diagnostic radiation thresholds.

During consolidation (typically 3 months post-expansion in MARPE protocols), nasal floor and paranasal anatomy continue to remodel as neobone fills the expanded suture. CBCT imaging at this consolidation endpoint (T2 in research protocols) reveals whether bony bridging is uniform across the midpalatal suture, a sign of stable skeletal expansion, or whether gaps remain, suggesting incomplete suture separation and a higher relapse risk.

Research protocols using low-dose CBCT demonstrate that MARPE-induced nasal floor widening persists through the consolidation phase, with measurements stabilizing by three months post-expansion.
CLINICAL EFFECTS
*Why these changes matter for your patients*

Airway function, dentoalveolar effects, and
long-term stability
implications of nasal floor remodeling

The expansion of the nasal floor and widening of the nasal cavity have direct implications for nasal airway resistance and function. Clinically, many patients report improved nasal breathing and reduced snoring during or shortly after the active MARPE phase, a benefit that correlates with documented nasal cavity widening on CBCT. This airway improvement is a potential quality-of-life benefit and may influence patient compliance during the active expansion and consolidation phases. However, not all nasal floor widening translates uniformly to airway improvement. The relationship between skeletal nasal widening and functional airway patency depends also on soft-tissue adaptation (mucosal swelling, septate deviation, adenoid size) and individual anatomical variation.

A critical clinical distinction exists between MARPE and tooth-borne RPE in terms of dentoalveolar side effects. Because MARPE distributes transverse forces through skeletal anchorage rather than dental crowns, the anchor teeth undergo significantly less buccal tipping and root divergence than in conventional RPE. This occurs because the skeletal force is applied closer to the center of resistance of the maxilla, and because the miniscrews are positioned at the palatal midline, orthopedic force transfer is more direct and less likely to induce unwanted dental movements. Clinical consequence: MARPE cases typically require less orthodontic decompensation in the transverse plane during the alignment phase, reducing overall treatment time and final dentoalveolar compromises.

Regarding long-term stability, nasal floor remodeling appears to be a stable collateral change. Unlike dental expansion (which relies on periodontal stretch and rebound), skeletal expansion is supported by neobone formation and sutural remodeling. CBCT evidence demonstrates that nasal width gains persist during the consolidation phase and beyond, although long-term (5+ year) stability data in MARPE cohorts remain limited. The consolidation period protocol — typically 6 months of retention with the appliance in situ — allows neobone to mature and provides a biological window for secondary skeletal and dentoalveolar stabilization. Clinicians must design post-consolidation retention (fixed palatal or maxillary retention devices) with nasal floor anatomy in mind. Retention appliances that restrict transverse rebound will enhance stability of nasal floor widening gains.

Clinical observation supported by CBCT evidence: MARPE-induced nasal floor widening correlates with reduced dentoalveolar side effects and improved nasal airway dimensions compared to tooth-borne expansion.
CLINICAL PROTOCOL
*Integrate nasal floor monitoring into your MARPE workflow*

Pre-treatment baseline, intra-treatment verification, and
post-consolidation assessment
protocols for nasal floor remodeling

An evidence-based MARPE protocol must include specific imaging and measurement steps to monitor nasal floor remodeling and optimize treatment outcomes. Pre-treatment CBCT imaging should establish baseline nasal floor width, vomer position, paranasal sinus anatomy, and greater palatine foramen dimensions. These measurements serve two purposes: (1) they document the patient's starting anatomy, allowing objective quantification of treatment effects, and (2) they identify anatomical contraindications or risk factors (e.g., severe septal deviation, asymmetric nasal anatomy, or narrow nasal cavity that may limit expansion) that should influence case selection or protocol modification.

During the active expansion phase (typically 1–2 weeks of activation followed by weekly check-ups), nasal floor remodeling occurs continuously but is not easily assessed on intraoral photographs or models. A strategic intermediate CBCT scan — performed at the end of the active expansion phase (T1 in research protocols), approximately 8–12 weeks post-placement — provides confirmation that skeletal nasal widening is occurring as expected and that anchor teeth are not undergoing excessive buccal displacement. This intra-treatment CBCT has high clinical utility: if nasal floor widening is suboptimal or asymmetric, the clinician can adjust activation frequency, verify miniscrew stability, or consider surgical corticotomy assistance (in adults with heavily fused sutures).

A second CBCT scan at the end of the consolidation phase (T2, approximately 3 months after final activation) serves as a quality control endpoint. This imaging confirms (1) uniform neobone fill across the expanded midpalatal suture, (2) stable nasal floor width and paranasal remodeling, (3) adequate anchor tooth position (minimizing buccal flaring), and (4) absence of iatrogenic complications (e.g., root resorption, miniscrew failure, or unexpected sinus pathology). Post-consolidation CBCT also provides the final baseline for long-term follow-up. If a patient returns years later with relapse concerns, the post-MARPE CBCT documents the skeletal gains achieved and provides objective data for retreat decision-making.

Dr. Mark Radzhabov emphasizes that nasal floor remodeling should be measured at standardized anatomical points (molar region nasal width [M-NW], premolar region [PM-NW], and vomer position relative to anterior nasal spine) to ensure reproducibility and allow comparison across cases and published literature. Digital CBCT measurement tools built into platforms such as Anatomage InVivo enable clinicians to perform these analyses without external software, making nasal floor monitoring accessible to the typical orthodontic practice.

Clinical protocol based on prospective randomized evidence: pre-treatment baseline, intra-treatment verification (T1), and post-consolidation assessment (T2) with standardized nasal floor measurements optimize MARPE outcome monitoring.
PITFALLS & TROUBLESHOOTING
*Common missteps and how to avoid them*

Asymmetric nasal floor remodeling, incomplete
suture separation
and relapse risk factors

Despite standardized MARPE protocols, nasal floor remodeling does not always proceed symmetrically. Anatomical asymmetries present before treatment (e.g., deviated vomer, unequal nasal cavity width, or asymmetric paranasal sinus pneumatization) can amplify during expansion, resulting in unequal nasal floor widening that may exacerbate breathing complaints on one side or create esthetic asymmetry. Asymmetric nasal floor expansion is not necessarily a complication. It often reflects underlying skeletal asymmetry that becomes apparent only when the nasal cavity is widened. Pre-treatment CBCT baseline analysis is the only reliable method to detect and counsel patients regarding this risk before treatment begins.

Incomplete midpalatal suture separation is a significant risk factor for nasal floor remodeling failure and treatment relapse. If the midpalatal suture does not separate adequately — indicated on intra-treatment CBCT (T1) by persistent bony bridging or narrow gaps — nasal floor widening will be limited, and the expansion achieved will rely primarily on dentoalveolar compensation (buccal tipping of anchor teeth) rather than skeletal remodeling. In such cases, the clinician should consider surgical corticotomy assistance (perforations placed along the midpalatal suture to disrupt bony ankylosis and reduce suture density) or extend the activation protocol. Early detection via intermediate CBCT prevents months of futile activation in cases with underlying skeletal impedance.

Relapse of nasal floor width gains occurs primarily in the absence of adequate consolidation and retention. Post-consolidation retention protocols must maintain transverse maxillary dimensions. A removable Hawley appliance or a wraparound design is suboptimal for this purpose. Fixed palatal wire or bonded maxillary lingual retention spanning the full transverse width provides superior nasal floor width stability and is the retention standard for MARPE cases. Additionally, retention duration should exceed typical fixed-appliance cases. At minimum, 12–24 months of full-time fixed retention followed by long-term part-time or nighttime wear is recommended. The biological window for secondary bony maturation extends well beyond the 3-month consolidation phase, and premature retention removal invites dentoalveolar and skeletal rebound.

Miniscrew failure during the activation phase is a rare but serious complication that immediately halts nasal floor remodeling and forces case abandonment or replacement of the failed screw. Risk factors include poor initial screw insertion torque, placement in insufficiently dense bone, or high-cycle loading (overly frequent activation). Verification of adequate screw stability at each visit, using the mobility index (gentle probe pressure at the screw head), is a simple but often-overlooked quality control step that can prevent mid-treatment screw loss.

Clinical experience indicates that asymmetric nasal floor remodeling, incomplete suture separation, inadequate retention, and miniscrew failure are the primary causes of suboptimal nasal floor outcomes in MARPE cases.
MARPE & Skeletal Expansion Course

Learn the full MARPE protocol from Dr. Mark Rajabov

Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.

Mini Course — RPE & Skeletal Expansion

Essentials of rapid palatal expansion for practicing orthodontists.

  • Core RPE concepts and biomechanics
  • 6 structured video lessons
  • Clinical decision checklists
  • Lifetime access to recordings
Explore Mini Course
Effective Patient Consultation

5-element medical consultation framework for dentists and orthodontists.

  • Trust-building consultation protocol
  • 5 lesson modules
  • Templates for treatment plan delivery
  • Works with any clinical specialty
Explore Consultation
Frequently Asked Questions

Clinical FAQ

How much does the nasal floor widen during MARPE compared to conventional RPE?

Prospective randomized trials show MARPE produces significantly greater increases in molar region nasal width (M-NW) and greater palatine foramen dimensions than identical 35-turn RPE activation protocols. The difference reflects skeletal versus dentoalveolar force distribution.

What is the clinical significance of greater palatine foramen widening in MARPE?

Greater palatine foramen widening reflects midpalatal suture separation depth and skeletal expansion magnitude. Measuring foramen width on CBCT provides an objective quality-control metric to verify adequate orthopedic response during treatment.

Can nasal floor remodeling be observed on intraoral photographs or study models during MARPE?

No. Nasal floor and paranasal remodeling are three-dimensional skeletal changes visible only on CBCT imaging. Clinical photographs and models do not show internal nasal anatomy, so intermediate CBCT is essential for intra-treatment outcome verification.

Do all patients experience improved nasal breathing after MARPE?

No. Nasal airway improvement correlates with nasal cavity widening, but soft-tissue factors (mucosal adaptation, septate deviation, adenoid size) and individual anatomical variation influence functional outcomes. Baseline airway assessment helps set realistic patient expectations.

How should retention be designed after MARPE to maintain nasal floor width gains?

Fixed palatal or bonded maxillary lingual retention spanning full transverse width is superior to removable appliances. Maintain for 12–24+ months. Skeletal expansion gains, including nasal floor widening, require rigid retention to resist rebound.

What does asymmetric nasal floor widening indicate on post-MARPE CBCT?

Asymmetric nasal expansion often reflects underlying skeletal asymmetry (deviated vomer, unequal nasal cavity width) that becomes apparent only when the nasal cavity is widened. Pre-treatment CBCT baseline analysis identifies this risk and allows informed case selection.

How long should the consolidation period last after completing MARPE activation?

Standard consolidation is 3 months minimum, during which neobone matures and fills the expanded midpalatal suture. Some protocols extend consolidation to 6 months to ensure uniform bony bridging and reduce relapse risk.

Can miniscrew failure during MARPE be prevented?

Yes. Adequate initial insertion torque (25–45 Ncm depending on bone density), placement in sufficient bone depth, appropriate activation frequency (typically 3–4 turns per day initially, then reduced), and routine mobility assessment minimize screw failure risk.

What anatomical features on pre-treatment CBCT contraindicate MARPE?

Severe anatomical constraints include extremely narrow nasal cavity, heavily fused midpalatal suture in adults (consider surgical SARPE or corticotomy), miniscrew placement zones with insufficient bone height or density, and unstable dental or skeletal base pathology. Individual case analysis is essential.

How does Dr. Mark Radzhabov assess nasal floor remodeling in routine clinical practice?

Structured MARPE protocol includes pre-treatment baseline CBCT, intra-treatment verification CBCT at end of active expansion (8–12 weeks), and post-consolidation CBCT (3 months) with standardized nasal floor measurements at molar and premolar levels using digital CBCT software.

MARPE's influence on the nasal floor and paranasal anatomy represents a significant clinical advantage over conventional tooth-borne expansion, particularly in non-growing patients where skeletal anchorage allows more orthopedic force transfer to midline and lateral structures. Clinicians who recognize and monitor nasal floor remodeling during treatment can better counsel patients on airway benefits, identify cases prone to relapse, and refine retention protocols. Dr. Mark Radzhabov's evidence-based approach emphasizes pre-treatment three-dimensional imaging analysis to baseline these structures and mid-treatment CBCT confirmation to verify favorable skeletal response. To deepen your mastery of MARPE biomechanics and collateral anatomical changes, consider reviewing a detailed case study or enrolling in the structured MARPE protocol course at Orthodontist Mark — your next complex expansion case depends on this anatomical literacy.

Contact us:
Email: support@ortodontmark.com
If you still have questions,
message us on WhatsApp.
Interested in the course?
Contact us – we’ll help you choose the right program!
WhatsApp
Messenger
E-mail